HPM

CEO Spotlight: Acurx Pharmaceuticals in Focus with CEO David Luci Talking Potentially Transformative Phase 2b Trial, Pipeline, and Potential Near-Term Catalysts

Monday, September 13, 2021 - 2:48pm

Acurx Pharmaceutical's CEO tells Soulstring Media why he thinks 2021-22 can be a breakout year for his company

Key Points: 
  • Rather than speculate on each drug's market potential, HPM reached out to Mr. David Luci, CEO of Acurx, allowing him to respond to investor questions.
  • Acurx is outside that mold because we have a new class of antibiotics treating life-threatening infections with two in the class.
  • Our scientific team has indicated publicly that these data portend future success in Phase 2b and Phase 3.
  • Q: The Phase 2b trial can be transformative to Acurx, especially if data proves superior to standard of care Vancomycin in the imminent head-to-head match-up.

CEO Spotlight: Acurx Pharmaceuticals in Focus with CEO David Luci Talking Potentially Transformative Phase 2b Trial, Pipeline, and Potential Near-Term Catalysts

Monday, September 13, 2021 - 1:03pm

Acurx Pharmaceutical's CEO tells Soulstring Media why he thinks 2021-22 can be a breakout year for his company

Key Points: 
  • Rather than speculate on each drug's market potential, HPM reached out to Mr. David Luci, CEO of Acurx, allowing him to respond to investor questions.
  • Acurx is outside that mold because we have a new class of antibiotics treating life-threatening infections with two in the class.
  • Our scientific team has indicated publicly that these data portend future success in Phase 2b and Phase 3.
  • Q: The Phase 2b trial can be transformative to Acurx, especially if data proves superior to standard of care Vancomycin in the imminent head-to-head match-up.

Epirus, Inc. Raises $70M in Series B Funding, Advancing Directed Energy For Defense and Commercial Applications

Thursday, December 17, 2020 - 2:00pm

Epirus, Inc ., a high growth technology company that is rapidly developing and building software defined high-powered microwave (HPM) applications for the defense and commercial sectors, has announced $70M in Series B financing led by Bedrock Capital.

Key Points: 
  • Epirus, Inc ., a high growth technology company that is rapidly developing and building software defined high-powered microwave (HPM) applications for the defense and commercial sectors, has announced $70M in Series B financing led by Bedrock Capital.
  • Additionally, L3Harris Technologies is investing in Epirus to partner on creating greater power efficiencies within some of their existing systems.
  • Underscoring its mission to broaden and enhance the supply of directed energy services across multiple applications and industries, and to protect America and its allies with innovative technology, the Series B funding will be utilized to help manufacture and bolster Epirus state-of-the-art SmartPower technology.
  • With our foothold in the defense industry, weve invented directed energy systems that surpass current capabilities.

Kratos Receives $46 Million Directed Energy Award in Support of U.S. Army

Tuesday, June 16, 2020 - 9:00pm

The prototype project is to establish a Directed Energy (DE) Testbed to accelerate military development capability in the focus areas of High Energy Laser (HEL) and/or High Power Microwave (HPM) systems.

Key Points: 
  • The prototype project is to establish a Directed Energy (DE) Testbed to accelerate military development capability in the focus areas of High Energy Laser (HEL) and/or High Power Microwave (HPM) systems.
  • Work under this pOTA is anticipated to be performed at Kratos facilities and at government locations in Huntsville, AL.
  • Dave Carter, President of the Kratos Defense & Rocket Support Services (KDRSS) Division, said, "This recent award is another important milestone in our commitment to continue providing superior advanced technology solutions that is in keeping with our long term strategic goals supporting the U.S. Army in advancing and developing improved Directed Energy Technologies.
  • We are very pleased the U.S. Army has chosen Kratos to serve in this capacity."

Announcing Keynote Address by General Paul J. Selva, Vice Chairman Joint Chiefs of Staff

Tuesday, May 8, 2018 - 9:00pm

WASHINGTON, May 8, 2018 /PRNewswire/ --The Institute for Defense & Government Advancement announces that General Paul J. Selva, Vice Chairman Joint Chiefs of Staff will address the Directed Energy and Next Generation Munitions Event this June 25-27 in Washington, D.C.His Keynote presentation will address Strategic Overlook and Guidance for DE Employment in the Military.

Key Points: 
  • WASHINGTON, May 8, 2018 /PRNewswire/ --The Institute for Defense & Government Advancement announces that General Paul J. Selva, Vice Chairman Joint Chiefs of Staff will address the Directed Energy and Next Generation Munitions Event this June 25-27 in Washington, D.C.His Keynote presentation will address Strategic Overlook and Guidance for DE Employment in the Military.
  • Mr. William P. Bray, Deputy Assistant Secretary Navy Research, Development, Test and Evaluation
    2018 Directed Energy topics to be addressed include : Roadmap for High Power Microwave (HPM) Directed Energy (DE) Weapons, Governmental perspectives on Directed Energy Development, Acquisition and Force Integration, Joint Laser Systems Effectiveness, Lessons Learned and Future Plans for DEs Ground Mobile Platforms Operational Integration and Advancements in Power Re-Generation and Storage Solutions for DE Systems
    Visit https://distributedlethality.iqpc.com to learn more about the policies and operational considerations for the development and employment of these next-generation weapons.